Eden Innovations Ltd (AU:EDE)
ASX:EDE
Top Page
Eden Innovations
(Sydney:EDE)
Select Model
Select Model
Rating:43Neutral
Price Target:
AU$0.10
â–²(140.00% Upside)
Action:ReiteratedDate:03/20/26
The score is driven down primarily by very weak financial performance (losses, major revenue decline, negative equity, and negative cash flows). Technical indicators also lean bearish with negative momentum and the price below key moving averages. Valuation is only a modest offset due to a moderate P/E and no dividend support.
Positive Factors
High Gross Margin
A gross margin near 69% signals strong product-level economics and pricing power, which are durable advantages. Even with current losses, high unit margins give management room to reduce overhead, scale production, and reach operating profitability as revenues stabilize over the next several months.
Negative Factors
Negative Equity / Solvency Risk
Negative shareholders' equity and a distorted debt-to-equity ratio indicate material solvency strain. Over 2-6 months this constrains borrowing, increases refinancing and dilution risk, and limits strategic flexibility, making it harder to fund recovery or invest without external capital injections.
Read all positive and negative factors
Positive Factors
Negative Factors
High Gross Margin
A gross margin near 69% signals strong product-level economics and pricing power, which are durable advantages. Even with current losses, high unit margins give management room to reduce overhead, scale production, and reach operating profitability as revenues stabilize over the next several months.
Read all positive factors
Eden Innovations (EDE) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$67.97M
Dividend YieldN/A
Average Volume (3M)1.01M
Price to Earnings (P/E)10.2
Beta (1Y)0.90
Revenue Growth20.65%
EPS Growth15.54%
CountryAU
Employees35
SectorIndustrials
Sector Strength72
IndustryIndustrial - Machinery
Share Statistics
EPS (TTM)<0.01
Shares Outstanding578,463,800
10 Day Avg. Volume807,653
30 Day Avg. Volume1,006,652
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-4.66
Price to Sales (P/S)3.35
P/FCF Ratio-2.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Eden Innovations Business Overview & Revenue Model
Company Description
Eden Innovations (EDE) is an innovative company focused on providing advanced solutions in the field of clean energy and sustainable technologies. Primarily operating in the sectors of hydrogen generation and carbon capture, Eden Innovations speci...
How the Company Makes Money
null...
Eden Innovations Financial Statement Overview
Summary
Income Statement
20
Very Negative
Balance Sheet
15
Very Negative
Cash Flow
25
Negative
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.69M | 2.43M | 2.02M | 4.70M | 4.15M | 3.28M |
| Gross Profit | -696.84K | 1.68M | 1.39M | -2.17M | -3.36M | -3.10M |
| EBITDA | -2.84M | -3.93M | -4.83M | -15.08M | -4.49M | -3.73M |
| Net Income | -330.41K | -6.93M | -7.55M | -17.87M | -6.65M | -5.76M |
Balance Sheet | ||||||
| Total Assets | 17.99M | 17.84M | 19.07M | 17.00M | 25.79M | 24.48M |
| Cash, Cash Equivalents and Short-Term Investments | 3.66M | 561.18K | 975.20K | 2.53M | 1.55M | 2.18M |
| Total Debt | 3.89M | 16.34M | 12.79M | 10.21M | 4.91M | 5.26M |
| Total Liabilities | 6.63M | 19.59M | 15.10M | 12.28M | 6.30M | 6.34M |
| Stockholders Equity | 11.36M | -1.75M | 3.98M | 4.73M | 19.49M | 18.14M |
Cash Flow | ||||||
| Free Cash Flow | -3.18M | -3.70M | -5.27M | -5.11M | -7.51M | -7.46M |
| Operating Cash Flow | -3.18M | -3.70M | -5.22M | -4.17M | -6.03M | -5.55M |
| Investing Cash Flow | 6.34M | -305.20K | -586.79K | -940.93K | -1.48M | -1.91M |
| Financing Cash Flow | 1.01M | 3.59M | 4.26M | 6.09M | 6.78M | 8.45M |
Eden Innovations Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
54 Neutral | AU$5.20B | 38.82 | 3.98% | 2.32% | 2.39% | ― | |
54 Neutral | AU$78.00M | -82.07 | 6.56% | ― | 13.51% | 5.08% | |
48 Neutral | AU$30.70M | -16.21 | -15.66% | ― | 11.53% | 46.15% | |
43 Neutral | AU$67.97M | 10.16 | -6.88% | ― | 20.65% | 15.54% | |
42 Neutral | AU$8.12M | -2.69 | -41.16% | ― | -45.80% | -210.00% | |
41 Neutral | AU$37.86M | -7.05 | -38.77% | ― | ― | 15.66% |
* Industrials Sector Average
AU:EDE
Eden Innovations
0.12
0.09
317.86%
AU:PET
Phoslock Environmental Technologies Limited
0.01
-0.01
-48.00%
AU:CWY
Cleanaway Waste Management
2.32
-0.24
-9.48%
AU:EGL
Environmental Group Limited
0.21
-0.03
-10.87%
AU:ECT
Environmental Clean Technologies Limited
0.09
0.04
82.00%
AU:DEM
De.mem Ltd.
0.09
<0.01
4.44%
Eden Innovations Corporate Events
Eden Innovations Seeks ASX Quotation for New Share Issue
Mar 31, 2026
Eden Innovations Ltd has applied for quotation on the ASX of 62,017 new ordinary fully paid shares, to be issued on 31 March 2026. The modest share issuance, arising from the exercise or conversion of existing options or other convertible securiti...
Eden Innovations Deepens EdenCrete Penetration in Americas Ready-Mix Market
Mar 25, 2026
Eden Innovations reported continued penetration of its EdenCrete Pz7 and EdenCrete products across North and South America, with bulk storage and dispensing systems now installed or in the pipeline at 29 ready-mix concrete plants. Key customers in...
Eden Innovations Corrects ASX Filing on Newly Quoted Shares
Mar 19, 2026
Eden Innovations has amended a previous filing with the ASX to correct the number of new shares being quoted following the exercise of options or conversion of other securities. The updated Appendix 2A, dated 19 March 2026, revises the figure from...
Eden Innovations Seeks ASX Quotation for Additional Ordinary Shares
Mar 17, 2026
Eden Innovations Ltd has applied to the ASX for quotation of 1,036,007 new ordinary fully paid shares, with an issue date of 17 March 2026. The securities result from the exercise or conversion of existing options or other convertible instruments,...
Eden Innovations Rides Data Centre Boom With Surging U.S. OptiBlend Sales
Mar 15, 2026
Eden Innovations reported strong growth in U.S. OptiBlend sales, with revenue from the dual fuel kits exceeding US$1.18 million in the first 8.5 months of FY2026, more than 65% above the total OptiBlend revenue for all of FY2025. Since early Febru...
Eden Innovations Issues New Shares on Option Exercise and Confirms Regulatory Compliance
Mar 2, 2026
Eden Innovations has issued 2,507,505 fully paid ordinary shares following the exercise of an equivalent number of options priced at $0.07 each, including 607,428 shares allocated to a sophisticated investor under a shortfall offer linked to a pre...
Eden Innovations Seeks ASX Quotation for 2.5 Million New Shares
Mar 2, 2026
Eden Innovations has applied for quotation on the ASX of 2,507,505 new ordinary fully paid shares, with an issue date of March 2, 2026. The move modestly expands the company’s quoted share capital, potentially affecting liquidity and ownersh...
Eden Innovations Swings to Half-Year Profit on U.S. Property Sale
Feb 27, 2026
Eden Innovations reported a 14% decline in revenue to A$1.15 million for the half year to 31 December 2025, reflecting lower contributions from Optiblend kit sales in the U.S. and India. However, the company’s net result swung to a A$963,000...
Eden Innovations Targets AI Data Centres With Carbon Nanotube Concrete R&D Push
Feb 25, 2026
Eden Innovations has decided to invest in new research and development equipment to expand the application of its carbon nanotube-enriched concrete technology to address the specialised needs of rapidly growing AI and cloud data centres. The compa...
Eden Innovations Sees Surging U.S. Data Centre Demand for OptiBlend Dual Fuel Kits
Feb 24, 2026
Eden Innovations reported accelerating demand in the U.S. for its OptiBlend dual fuel kits, particularly from data centres using diesel generators for backup power. Since September 2025, the company has sold or received firm orders for nine OptiBl...
Eden Innovations Issues 2.2 Million Unquoted Convertible Notes
Feb 9, 2026
Eden Innovations Ltd has notified the market of the issue of a new class of unquoted convertible notes, with a total of 2,200,000 securities to be issued on 9 February 2026. The notes form part of a previously announced transaction, are not quoted...
Eden Innovations Seeks ASX Quotation for 20 Million New Options
Feb 9, 2026
Eden Innovations has applied to the ASX for quotation of a new class of 20,000,000 options under the code EDEAU, each exercisable at A$0.07 and expiring on 8 September 2027. The listing of these options expands the company’s tradable securit...
Eden Innovations Applies for Quotation of New ASX Option Class
Feb 9, 2026
Eden Innovations has lodged an application with the ASX for quotation of a new class of options, exercisable at $0.07 and expiring on 8 September 2027. The 1,000 options, issued as cleansing options to facilitate secondary trading and quotation of...
Eden Innovations Seeks ASX Quotation for 131 Million Options
Feb 9, 2026
Eden Innovations has applied to the ASX for quotation of 131,177,806 options previously issued under an option cleansing prospectus, with the options exercisable at $0.07 and expiring on 8 September 2027. The options are spread across several issu...
Eden Innovations Names New Managing Director as Global Demand and Balance Sheet Strengthen
Feb 9, 2026
Eden Innovations has appointed longtime executive and chief scientist Dr Allan Godsk Larsen as managing director to lead its next phase of global expansion, leveraging his deep expertise in carbon material chemistry and his role in developing the ...
Eden Innovations Seeks ASX Quotation for Options and Reveals Top Holders
Feb 5, 2026
Eden Innovations Ltd has applied for ASX quotation of options previously issued to shareholders and investors who participated in its entitlement and entitlement shortfall offers, with the options exercisable at $0.07 each and expiring on 8 Septem...
Eden Innovations Confirms Compliance After Shortfall Share Issue
Feb 4, 2026
The company issued 341,780 fully paid ordinary shares after the exercise of options, including 100,001 shortfall shares taken up by a sophisticated investor under last year’s entitlement offer. Eden Innovations affirmed full compliance with ...
Eden Innovations Files Appendix 3B for Small Option Issue
Feb 4, 2026
Eden Innovations has lodged an Appendix 3B outlining plans to issue 1,000 options exercisable at A$0.07 and expiring on 8 September 2027, signalling a modest capital-raising move that could bolster liquidity and fund near-term development initiati...
Eden Innovations Lodges Cleansing Prospectus to Lift Trading Restrictions on Options
Feb 4, 2026
Eden Innovations Ltd has released an options cleansing prospectus for an offer of 1,000 Cleansing Options at no issue price, primarily to remove trading restrictions on existing options of the same class on issue before the closing date of 6 Febru...
Eden Innovations Seeks ASX Quotation for Additional Ordinary Shares
Feb 4, 2026
Eden Innovations Ltd has applied to the ASX for quotation of 341,780 new ordinary fully paid shares, to be listed under its existing ticker EDE. The additional securities, issued on 4 February 2026 following the exercise or conversion of existing ...
Eden Innovations Cuts Debt and Ramps Up Global Sales of EdenCrete and OptiBlend
Jan 27, 2026
Eden Innovations has completed a major recapitalisation and debt refinancing, raising A$4.35 million through a placement and cutting total debt by about A$16 million via loan repayments, refinancing of high-interest borrowings, and conversion of s...
Eden Innovations Targets Indian Highway Market With New EdenCrete Pz7 Trials
Jan 27, 2026
Eden Innovations has begun larger-scale trials of its EdenCrete Pz7 concrete admixture in India in collaboration with the government’s Central Road Research Institute, targeting two widely used concrete grades (M60 and M40 PQC) employed in m...
Eden Innovations Plans Convertible Note and Option Issue to Boost Funding
Jan 11, 2026
Eden Innovations Ltd has lodged details of a proposed capital raising with the ASX, outlining plans to issue up to 2.2 million convertible notes and 20 million options exercisable at A$0.07 and expiring on 8 September 2027. The proposed placement,...
Eden Innovations Wipes Out High-Cost Debt with $2.2m Strategic Note
Jan 11, 2026
Eden Innovations has secured a $2.2 million strategic convertible note from 7 Enterprises Pty Ltd to eliminate its remaining $2.7 million iBorrow loan, removing a high‑cost debt facility that was costing more than $1 million annually in inte...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.